Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 31.95 INR
Change Today +2.00 / 6.68%
Volume 246.0
SMPM On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

samrat pharmachem ltd (SMPM) Snapshot

Open
29.00
Previous Close
29.95
Day High
33.30
Day Low
29.00
52 Week High
03/20/15 - 49.70
52 Week Low
03/4/15 - 20.10
Market Cap
98.7M
Average Volume 10 Days
1.7K
EPS TTM
1.02
Shares Outstanding
3.1M
EX-Date
--
P/E TM
31.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for SAMRAT PHARMACHEM LTD (SMPM)

Related News

No related news articles were found.

samrat pharmachem ltd (SMPM) Related Businessweek News

No Related Businessweek News Found

samrat pharmachem ltd (SMPM) Details

Samrat Pharmachem Limited produces and sells pharmaceutical chemicals primarily in India. The company primarily sells iodine and bromine salts. Its products include calcium iodate monohydrate, copper iodide, hydriodic acid, iodine, iodine monochloride, iodoethane, iodomethane, potassium bromide, potassium iodate, potassium iodide, potassium metaperiodate, sodium iodate, sodium iodide, sodium metaperiodate, and trimethyl sulfoxoniumiodide. The company’s finished products are primarily used in various industries, such as pharmaceuticals, chemicals, food, fertilizer, and salt. Samrat Pharmachem Limited also exports its products to the United States, Europe, and Japan. The company was incorporated in 1992 and is based in Mumbai, India.

Founded in 1992

samrat pharmachem ltd (SMPM) Top Compensated Officers

Chairman, Chief Executive Officer and Managin...
Total Annual Compensation: 480.0K
Executive Director of Finance, Executive Dire...
Total Annual Compensation: 420.0K
Compensation as of Fiscal Year 2014.

samrat pharmachem ltd (SMPM) Key Developments

Samrat Pharmachem Ltd Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Samrat Pharmachem Ltd. reported unaudited standalone earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, the company reported net income from sales/services of INR 91.769 million compared to INR 121.604 million a year ago. Loss from operations before other income, interests and exceptional items was INR 1.306 million compared to profit from operations before other income, interests and exceptional items of INR 4.277 million a year ago. Loss from ordinary activities before tax was INR 1.942 million compared to profit from ordinary activities before tax of INR 3.994 million a year ago. Net loss for the period was INR 0.893 million compared to net profit for the period of INR 3.488 million a year ago. For the full year, the company reported net income from sales/services of INR 473.944 million compared to INR 648.406 million a year ago. Profit from operations before other income, interests and exceptional items was INR 8.904 million compared to profit from operations before other income, interests and exceptional items of INR 9.480 million a year ago. Profit from ordinary activities before tax was INR 4.790 million compared to profit from ordinary activities before tax of INR 4.072 million a year ago. Net Profit for the period was INR 3.159 million compared to net profit for the period of INR 2.416 million a year ago.

Samrat Pharmachem Ltd, Board Meeting, May 30, 2015

Samrat Pharmachem Ltd, Board Meeting, May 30, 2015. Agenda: To consider the unaudited standalone earnings results for the fourth quarter and year ended March 31, 2015.

Samrat Pharmachem Ltd. Appoints Renu Dharod as Independent Director

Samrat Pharmachem Ltd. announced that Ms. Renu Dharod is appointed as an independent director of the company with effect from February 14, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SMPM:IN 31.95 INR +2.00

SMPM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SMPM.
View Industry Companies
 

Industry Analysis

SMPM

Industry Average

Valuation SMPM Industry Range
Price/Earnings 30.1x
Price/Sales 0.2x
Price/Book 0.7x
Price/Cash Flow 12.6x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAMRAT PHARMACHEM LTD, please visit www.samratpharmachem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.